Thermax Ltd THERMAX

Summary

Thermax is a Pune-headquartered energy-and-environment engineering group whose Industrial Products segment (~45% of FY26 revenue) houses a vapour-absorption chiller and heat-pump business increasingly marketed directly at hyperscale data-centre cooling. That positioning produced, per Q4 FY26 results commentary (~May 2026), what this report regards as the single most credible named large data-centre order found anywhere in its cooling category: a "breakthrough" order from a large US data centre for hot-water-driven absorption chillers totalling 45,000 tons of refrigeration (TR). The rupee value of that specific order was not disclosed in any source reached for this report, and it arrived inside a quarter in which total order inflows surged 112% YoY to ₹4,490 crore — the data-centre order is a genuine, confirmed contributor to that surge, not necessarily its majority.

Thermax also carries, on the evidence gathered, the strongest credit profile of any construction-adjacent name in this report: CRISIL reaffirmed CRISIL AA+/Stable/A1+ on 28 October 2025 (bank facilities later enhanced), and ICRA independently affirmed the same AA+/Stable/A1+ level in early 2026, both resting on a net-debt-free balance sheet with net worth over ₹4,750 crore. The company's order book grew to ₹14,045 crore (+23% YoY) by Q1 FY27, and its four-segment structure — Industrial Products, Industrial Infra, Green Solutions and Chemicals — spreads risk across a broader base than a pure-play cooling or pure-play EPC name would carry.

Set against that is a fact this report will not soften: Q1 FY27 (quarter ended June 2026) revenue rose 7% YoY to ₹2,303 crore, but PAT collapsed roughly 85-86% YoY to just ₹22 crore, with PBT margin compressing to 1.8% from 9.8% a year earlier — driven by a ₹91 crore one-off cost overrun on a legacy Industrial Infra project, plus losses in Green Solutions and Bio-CNG. The stock fell ~16% on the results. This matters beyond the single quarter: it demonstrates that even Thermax's more engineered, differentiated cooling franchise sits inside a corporate structure that is not fully insulated from the fixed-price, cost-overrun risk this report documents at commodity EPC players elsewhere in its universe. Management guides recovery only from Q3 FY27, meaning at least one more full quarter of residual risk remains on the company's own timeline. Against that miss, a trailing P/E of ~76.9x reads as elevated, not cheap.

Net: a HOLD. The US hyperscale chiller order and the AA+/A1+ credit profile are genuine, well-evidenced strengths — but a rich multiple sitting on top of an 85%+ quarterly profit miss, in a segment (Industrial Infra) management itself does not expect to normalise before Q3 FY27, leaves too little margin of safety for a BUY and too much underlying franchise quality for a SELL.

• A confirmed 45,000 TR US hyperscale absorption-chiller order — disclosed with Q4 FY26 results (~May 2026), this is the most credible named large data-centre order this report finds anywhere in the cooling category, marking Thermax's confirmed entry into the US/global hyperscale cooling supply chain via its Sri City-manufactured vapour-absorption chiller line. The order's rupee value was not disclosed.
• The strongest credit profile of any construction-adjacent company in this report. CRISIL AA+/ Stable/A1+ (reaffirmed 28 October 2025, rated bank facilities subsequently enhanced) and an independently affirmed ICRA AA+/Stable/A1+ (early 2026) — both resting on a net-debt-free balance sheet with net worth over ₹4,750 crore, a full notch or more above several EPC-style peers in this report's universe.
• Record order momentum. Q4 FY26 order inflows surged 112% YoY to ₹4,490 crore; the consolidated order book grew to ₹14,045 crore (+23% YoY) by Q1 FY27.
• A diversified four-segment franchise — Industrial Products (~45% of FY26 revenue, houses the chiller business), Industrial Infra (~41%, EPC), Green Solutions (~7%) and Chemicals (~7%) — reducing single-segment dependence relative to a pure-play cooling or pure-play EPC name.
• Disclosed further cooling-capacity investment. Management has referenced a planned expansion at the Sri City absorption-chiller plant specifically to meet data-centre-linked demand, though capex and timeline details were not disclosed in the sources reached.
• A cleaner leadership structure than several peers in this report. Chairperson Meher Pudumjee (non-executive, since October 2004) and MD/CEO Ashish Bhandari (a professional, non-family executive) hold separated roles, with family board presence limited to the non-executive chairpersonship.

• The Q1 FY27 profit collapse is the central reason for this report's caution. Revenue rose 7% YoY to ₹2,303 crore, but PAT fell ~85-86% YoY to just ₹22 crore, with PBT margin compressing to 1.8% from 9.8% a year earlier, driven by a ₹91 crore one-off cost overrun on a legacy Industrial Infra project plus losses in Green Solutions and Bio-CNG. The stock fell ~16% on the results. This is direct evidence that Thermax's EPC-adjacent Industrial Infra segment is not immune to the same fixed-price/cost-overrun risk that afflicts commodity EPC players elsewhere in this report, even though its core chiller/Industrial Products line is more engineered and differentiated.
• The trailing P/E of ~76.9x is elevated set against that miss. The market is, in effect, paying a "quality franchise" multiple for a company that just posted an 85%+ quarterly profit decline — a bet that the data-centre chiller story outweighs the Industrial Infra execution risk, which this report cannot independently confirm will resolve on schedule.
• Management guides recovery only from Q3 FY27 — meaning at least one more full quarter beyond the Q1 FY27 miss carries residual legacy-project risk before the company's own guidance expects normalisation to double-digit Industrial Infra margins.
• The 45,000 TR order's rupee value was never disclosed. Its materiality is real and directionally large — a confirmed hyperscale reference order — but this report cannot and does not quantify it as a percentage of total revenue or order book; no such figure should be inferred or invented.
• No confirmed named hyperscaler or Indian data-centre-operator customer was found beyond this single order. Thermax's disclosed data-centre exposure to date rests on one confirmed deal, not a diversified book of DC-specific business.
• Sell-side coverage is genuinely, unusually split. A Trendlyne-style aggregation of 20 analysts shows 6 Buy, 7 Sell and 8 Hold calls, with named targets ranging from JM Financial's Reduce/₹2,700 (January 2026) to a 52-week-high-implied ₹5,600 — a wide, contested range this report treats as genuine disagreement, not noise to be averaged away.
• Governance-verification gaps remain. This research could not confirm Thermax's statutory auditor, CFO, or litigation/related-party-transaction disclosures, and the often-cited "9 of 12 board members independent" figure was not independently cross-checked against the FY26 annual report's governance section.

• Q2 and Q3 FY27 results — the direct test of management's own guidance that legacy Industrial Infra issues clear and double-digit segment margins resume by Q3 FY27.
• Any disclosure of the 45,000 TR US chiller order's rupee value, or further named hyperscale orders, that would allow this report to size the data-centre business as a share of revenue.
• Sri City cooling-capacity expansion capex and timeline details, currently undisclosed.
• Clarification of the Q1 FY27 "merger okayed" reference and confirmation of the exact board composition and independent-director ratio from the FY26 annual report.

• Execution risk (dominant). Industrial Infra/legacy-project cost overruns, as evidenced by the Q1 FY27 miss; management's own guidance pushes recovery to Q3 FY27, leaving residual risk in the interim.
• Valuation risk. A ~76.9x trailing P/E leaves little room for a further disappointment in either Industrial Infra or the cooling franchise.
• Materiality/disclosure risk. The flagship data-centre order is a single, undisclosed-value data point, not yet a diversified DC customer book.
• Segment-level risk in Green Solutions/Bio-CNG, which also contributed losses to the Q1 FY27 miss.

We use approach (b): CMP ÷ disclosed trailing P/E. Given the Q1 FY27 profit collapse, a trailing-twelve- month EPS rebuilt bottom-up from quarterly PAT would be distorted by a single quarter management itself attributes to a one-off legacy-project cost overrun, and full-year FY27 earnings visibility does not return, on management's own guidance, until Q3 FY27. Rather than construct a forward-earnings forecast on a recovery timeline the company has not yet delivered, this report backs into a trailing EPS from the market's own disclosed multiple: CMP ₹3,552 ÷ trailing P/E 76.9x = trailing EPS of ~₹46.2 (18 Sep 2026, screener.in). We hold this EPS constant across all three scenarios and vary only the target multiple — a more defensible way to express bear/base/bull uncertainty here than fabricating a full-year FY27E EPS estimate around a recovery date management itself has only guided to, not confirmed:

Bear assumes the multiple compresses to 58x as Industrial Infra execution risk persists beyond Q3 FY27, closer to the multiple a market would assign a more commodity-style EPC franchise. Base assumes a modest compression to 74x from the current 76.9x, reflecting this report's view that the disclosed multiple is elevated set against the Q1 FY27 miss even before any further bad news; this rounds to a target of ₹3,419, or (3.7)% — comfortably within this report's HOLD band. Bull assumes an expansion to 88x as the data-centre chiller narrative dominates and the Q3 FY27 recovery is delivered on management's own timeline. Named brokerage targets found in this research span a genuinely wide, contested range: ICICI Securities upgraded to Buy with a ₹3,400 target (~6 February 2026, pre-dating the Q1 FY27 miss), JM Financial initiated at Reduce/₹2,700 (January 2026), and Trendlyne's 20-analyst consensus average is ₹4,199 (high ₹5,600, low ₹2,893) with an unusually even 6 Buy/7 Sell/8 Hold split. A separate aggregation citing "JM Financial: Neutral, ₹5,200" and "ICICI Securities: Neutral, ₹5,000" appears to reflect stale, pre-Q1-FY27 vintage data and should not be treated as current alongside the dated figures above.

Source: screener.in (18 Sep 2026), cross-checked against Q4 FY26 and Q1 FY27 results coverage (Business Standard, Investing.com, ICICIdirect, ~May-Jul 2026) and CRISIL/ICRA rating rationales (28 October 2025; Feb/Mar 2026).